We Can Help.

Contact us today for a complimentary consultation with a qualified attorney near you.

 
print page Bookmark and Share increase font size

Contact Us Today

Use this form to request a free consultation with a qualified attorney near you.

Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.

Zyprexa Warning

In 2004 the FDA ordered the pharmaceutical company Eli Lilly to include a Zyprexa warning about the serious side effect risks associated with this atypical antipsychotic prescription medication. This Zyprexa warning is the strongest warning that the FDA can order short of pulling a drug off the market. The Zyprexa warning is required to be located on all patient product packaging information and read aloud in all commercials. The Zyprexa warning contains information about the risks of diabetes, stroke, and death that are associated with this medication.

Zyprexa is an atypical antipsychotic that was approved by the FDA in 1996 to treat schizophrenia and bipolar disorder. Zyprexa is also prescribed "off label" by doctors who feel that this drug's use may prove beneficial to their patients for purposes other than those evaluated and approved by the government regulators. Zyprexa has been prescribed for other psychological conditions, particularly Alzheimer's and other types of dementia. Eli Lilly estimates that approximately six percent of its Zyprexa sales go to Alzheimer's and dementia patients.

In 2000 the Australian government issued a Zyprexa warning after over three hundred adverse Zyprexa side effects reports were made. In 2001, a Zyprexa warning was published in the American Medical Association journal stating that Zyprexa patients were ten times more likely to develop diabetes than the general population. In 2002, both the British and Japanese governments issued Zyprexa warning statements about the serious diabetes risks posed to Zyprexa users. While these foreign governments issued Zyprexa warning statements, the US government remained silent about these risks.

In 2002 Duke University issued a Zyprexa warning after findings from a large scale study indicated diabetes risks for Zyprexa patients. Duke, in conjunction with FDA experts, discovered nearly three hundred reports of Zyprexa users developing diabetes, 71 percent of whom developed this condition only six months after commencing Zyprexa treatment. Of these patients, one hundred also developed ketosis (a serious complication of diabetes), twenty two developed pancreatitis, and twenty three died from diabetes-related complications.

This Zyprexa warning prompted American officials to order Eli Lilly to include strong Zyprexa warning statements on all patient product information. Eli Lilly complied with this request, though they continued to deny that the risks of Zyprexa use outweighed the intended benefits of this blockbuster drug. The Zyprexa warning statements have continued since this time. Other reports have indicated that Zyprexa users are seven times more likely to develop treatment-emergent pancreatitis.

New studies have also found that elderly patients taking Zyprexa for Alzheimer's and dementia are twice as likely to die or suffer a serious stroke compared to patients in a control group. This Zyprexa warning has also been added to Zyprexa labeling. Despite all these Zyprexa warnings, the pharmaceutical company Eli Lilly still insists their product is safe.

For more information on Zyprexa warnings, please contact us to speak with a qualified lawyer.

More Zyprexa News:

January 17, 2007 - Zyprexa Lawsuit Filed Over Fatal Pancreatitis

December 18, 2006 - New Report Finds Eli Lilly Plays Down Zyprexa Risks

October 10, 2006 - Zyprexa Lawsuits Continue To Grow

August 11, 2006 - Zyprexa Victims To Receive Payout

July 31, 2006 - Mississippi Attorney General Sues Over Zyprexa

January 10, 2006 - Class action suit filed over Zyprexa

April 12, 2005 - Elderly patients warned of Zyprexa risks

April 11, 2005 - Zyprexa warning issued

February 9, 2005 - Zyprexa, Zyrtec prescription mix-ups result in hospitalizations

February 5, 2005 - Zyprexa lawsuit on behalf of Canadians filed

October 25, 2004 - Antipsychotics linked to serious adulthood diseases

May 21, 2004 - Nationwide Zyprexa class action lawsuit filed

More Zyprexa Resources:

Zyprexa Side Effects Lawyer - Provides details on the Zyprexa bipolar-disorder drug and its side effects, including withdrawal information. Contact an attorney for a consultation.

Zyprexa - Includes information for patients with schizophrenia.

Contact a Zyprexa Recall Lawyer

More Zyprexa Resources